PTGS2/Cox2 Mouse Monoclonal Antibody
Catalog #:EAB22133
Host / Isotype Clonality Applications MW (kDa) Reactivity
Mouse IgG2b Monoclonal WB, IHC-P, IF/ICC, ELISA 69 Human
Application Key

WB-Western Blot IP-Immunoprecipitation IHC-Immunohistochemistry IF-Immunofluorescence ICC-Immunocytochemistry FC-Flow Cytometry

Reactivity Key

H-Human M-Mouse R-Rat Mk-Monkey B-Bovine Pg-Pig Hm-Hamster Dg-Dog C-Chicken X-Xenopus Z-Zebrafish Hr-Horse All-All Species Expected

Applications Dilutions
The application notes include recommended starting dilutions;optimal dilutions/concentrations should be detemined by the end user.
WB(Westem Blotting)
IHC-P(Immunohistochemistry-Paraffin)
IF/ICC(Immunofluorescence/Immunocytochemistry)
ELISA(Enzyme-linked Immunosorbent Assay)
WB=1:500-2000 
IHC-P=1:100-500 
IF/ICC=1:100-500
Product Information
Conjugate Unconjugate
Specificity PTGS2/Cox2 Mouse Monoclonal Antibody detects endogenous levels of PTGS2/Cox2 protein.
Purification Affinity purification
Concentration 1mg/ml
Format Liquid
Formulation In PBS, pH 7.4, containing 0.02% sodium azide,0.5% BSA and 50% glycerol.
Shipping Gel Pack
Storage Store at -20°C least 1 year from the date of shipment. avoid repeated freeze/thaw cycles. Aliquots may be stored at +4°C for 1-2 weeks.
UniProt ID

P35354

Entrez Gene ID

5743

Product Description

Cox2 also known as PTGS2 is an inducible enzyme that plays a pivotal role in the conversion of arachidonic acid to prostaglandins, which are lipid mediators involved in inflammation, pain, and fever. Unlike its constitutively expressed isoform Cox1, Cox2 is minimally expressed under normal physiological conditions but is significantly upregulated in response to inflammatory stimuli, cytokines, growth factors, and tumor promoters. This upregulation leads to increased production of prostaglandins, contributing to the inflammatory response and pain perception. Overexpression of Cox2 has been implicated in various pathological conditions, including chronic inflammation, arthritis, and the progression of certain cancers such as colorectal, breast, and lung cancer. Cox2 is a key therapeutic target for nonsteroidal anti-inflammatory drugs (NSAIDs) and selective Cox2 inhibitors (coxibs), which aim to reduce inflammation and pain by inhibiting prostaglandin synthesis.

Product Image Gallery
For Research Use Only, Not For Diagnostic Or Therapeutic Procedures.
EbioCell Lifescineces, Inc.   Order:400-117-0038   order@ebiocell.com   Support: tech@ebiocell.com   Web:ebiocell.com